Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased titer of anti-beta2-glycoprotein I IgG antibody among factor V Leiden carriers during oral contraceptive use.

Contraception - 1 Jan 2004

Póka R, Vad S, Lakos G, Bereczki Z, Kiss E, Sipka S

Abstract excerpt

The risk of thromboembolism during oral contraceptive (OC) use is increased among factor V Leiden (FVL) carriers compared to women with wild-type genotype of the gene for coagulation factor V (FV). The carrier frequency in the general population is too high for FVL alone to be responsible for the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Antiphospholipid
Share to Anticoagulants
Share to beta 2-Glycoprotein I

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Contraceptives, Oral

Share to Factor V

Share to Glycoproteins

Share to Immunoglobulin G

Share to Thromboembolism

Source

Identifiers

PMID: 14720616
DOI: 10.1016/j.contraception.2003.08.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-14720616-2026-09-02.1. Manifest publication-graph-cohort-2026-09-02.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Increased titer of anti-beta2-glycoprotein I IgG antibody among factor V Leiden carriers during oral contraceptive use.PMID 14720616Read ↗

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.Semantic proximity Read ↗

Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?Semantic proximity Read ↗

Factor V Leiden as a common genetic risk factor for venous thromboembolism.Semantic proximity Read ↗

Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.Semantic proximity Read ↗

Factor V Leiden: should all women be screened prior to commencing the contraceptive pill?Semantic proximity Read ↗

Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use.Semantic proximity Read ↗

[Oral contraception increases the chance of venous thrombosis in factor V Leiden mutation].Semantic proximity Read ↗

Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (Beta2GPI) polymorphism and anti-Beta2GPI antibodies.Semantic proximity Read ↗

Oral contraceptives and screening for factor V Leiden.Semantic proximity Read ↗

Screening for factor V Leiden mutation before prescribing combination oral contraceptives.Semantic proximity Read ↗

Oral contraceptives highlight the genotype-specific association between serum phospholipids and activated factor VII.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.